Search Results
10
Everything
Castellum Announces Pricing of $4.5 Million Public Offering of Common Stock and Warrants
March 16, 2025 21:10 ET
|
Castellum, Inc.
Castellum Announces Pricing of $4.5 Million Public Offering of Common Stock and Warrants
Castellum Announces Pricing of $3.7 Million Public Offering of Common Stock
December 27, 2024 09:00 ET
|
Castellum, Inc.
Castellum Announces Pricing of $3.7 Million Public Offering of Common Stock
Castellum, Inc. Announces Proposed Public Offering of Common Stock
December 26, 2024 20:00 ET
|
Castellum, Inc.
Castellum, Inc. (CTM) Announces Proposed Public Offering of Common Stock
Castellum, Inc. Announces Pricing of $3.6 Million Registered Direct Offering
December 23, 2024 06:50 ET
|
Castellum, Inc.
Castellum, Inc. Announces Pricing of $3.6 Million Registered Direct Offering
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 08, 2024 08:30 ET
|
Femasys Inc.
ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 08, 2024 08:15 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., Oct. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and...
Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 08, 2024 08:00 ET
|
Indaptus Therapeutics
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will participate in a fireside chat at the...
Castellum Announces Closing of $2.7 Million Registered Direct Offering
January 29, 2024 16:30 ET
|
Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) closes on registered direct offering, consisting of the sale of 8,437,501 shares.
Castellum Announces Pricing of $2.7 Million Registered Direct Offering
January 25, 2024 08:55 ET
|
Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) has entered into a securities purchase agreement with an institutional investor to purchase 8,437,501
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC
June 14, 2023 09:15 ET
|
Atossa Therapeutics, Inc.
SEATTLE, June 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant...